126 related articles for article (PubMed ID: 67885)
1. An evaluation of leukocyte adherence inhibition in the immunodiagnosis of colorectal cancer.
Halliday WJ; Maluish AE; Stephenson PM; Davis NC
Cancer Res; 1977 Jul; 37(7 Pt 1):1962-71. PubMed ID: 67885
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
3. Experiences with leukocyte adherence inhibition in human cancer.
Maluish AE
Cancer Res; 1979 Feb; 39(2 Pt 2):644-8. PubMed ID: 367590
[No Abstract] [Full Text] [Related]
4. Identification of a Mr 40,000 polypeptide from colorectal cancer which expresses organ-specific cancer neoantigen activity as determined by leukocyte adherence inhibition.
Artigas C; Thomson DM; Durko M; Sutherland M; Scanzano R; Shenouda G; Dubois AE
Cancer Res; 1986 Apr; 46(4 Pt 1):1874-81. PubMed ID: 2418955
[TBL] [Abstract][Full Text] [Related]
5. Some immunologic characteristics of carcinoma of the colon and rectum.
Elias EG; Elias LL
Surg Gynecol Obstet; 1975 Nov; 141(5):715-8. PubMed ID: 1198304
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
Grosser N; Thomson DM
Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immunity and serum blocking factors in cancer patients during chemotherapy and immunotherapy.
Noonan FP; Halliday WJ; Wall DR; Clunie GJ
Cancer Res; 1977 Aug; 37(8 Pt 1):2473-80. PubMed ID: 872076
[TBL] [Abstract][Full Text] [Related]
8. Historical background and aspects of the mechanism of leukocyte adherence inhibition.
Halliday WJ
Cancer Res; 1979 Feb; 39(2 Pt 2):558-63. PubMed ID: 367582
[TBL] [Abstract][Full Text] [Related]
9. A collaborative study of a test for carcinoembryonic antigen (CEA) in the sera of patients with carcinoma of the colon and rectum. A joint National Cancer Institute of Canada-American Cancer Society investigation.
A Joint National Cancer Institute of Canada/American Cancer Society Investigation
Can Med Assoc J; 1972 Jul; 107(1):25-33. PubMed ID: 5042884
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the microleukocyte adherence inhibition assay as an immunodiagnostic test for pancreatic cancer.
Russo AJ; Douglass HO; Leveson SH; Howell JH; Holyoke ED; Harvey SR; Chu TM; Goldrosen MH
Cancer Res; 1978 Jul; 38(7):2023-9. PubMed ID: 77724
[No Abstract] [Full Text] [Related]
11. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
[TBL] [Abstract][Full Text] [Related]
12. The need to establish whether the leukocyte adherence inhibition test is a reliable assay of tumor immunity in humans.
Hellström KE; Hellström I
Cancer Res; 1979 Feb; 39(2 Pt 2):649-50. PubMed ID: 83919
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of the microtest version of the leukocyte adherence inhibition assay.
Goldrosen MH; Howell JH; Holyoke ED
Cancer Res; 1979 Feb; 39(2 Pt 2):630-2. PubMed ID: 367588
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two lymphokines (macrophage migration inhibition, leukocyte adherence inhibition factors) and carcinoembryonic antigen, in colorectal cancer and colonic premalignant lesions.
Shkolnik T; Livni E; Reshef R; Lachter J; Eidelman S
Am J Gastroenterol; 1987 Dec; 82(12):1275-8. PubMed ID: 3318403
[TBL] [Abstract][Full Text] [Related]
15. Organ specific neoantigens reactive in the leukocyte adherence inhibition assay: affinity purification of human colon carcinoma antigen and its cross-reactive protein using monoclonal antibodies.
Hadas E; Fink A; Gembom E; Harpaz N; Shani A; Bentwich Z; Eshhar Z
Cancer Res; 1986 Oct; 46(10):5201-5. PubMed ID: 2428475
[TBL] [Abstract][Full Text] [Related]
16. [Determination of the state of antitumor immunity and of serum blocking action in stomach cancer by using the leukocyte adherence inhibition reaction].
Grishchenko AM; Grinevich IuA; Alferov AN; Redkousova SF; Sen'ko LN
Vrach Delo; 1978 Aug; (8):28-32. PubMed ID: 695500
[No Abstract] [Full Text] [Related]
17. Hemocytometer leukocyte adherence inhibition technique.
Maluish AE; Halliday WJ
Cancer Res; 1979 Feb; 39(2 Pt 2):625-6. PubMed ID: 83916
[TBL] [Abstract][Full Text] [Related]
18. A comparison between the macrophage migration inhibition test (MMI) and the leucocyte adherence inhibition test (LAI) in patients with melanoma and carcinoma of the colon.
Isbister WH
N Z Med J; 1978 Oct; 88(622):327-30. PubMed ID: 366475
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of leukocytes of cancer patients against fetal antigens: leukocyte migration studies.
Zöller M; Matzku S; Schulz U; Price MR
J Natl Cancer Inst; 1979 Aug; 63(2):285-93. PubMed ID: 88534
[TBL] [Abstract][Full Text] [Related]
20. Microplate leucocyte adherence inhibition (LAI) assay in pancreatic cancer: detection of specific antitumor immunity with patients' peripheral blood cells and serum.
Goldrosen MH; Dasmahapatra K; Jenkins D; Howell JH; Arbuck SG; Moore MC; Douglass HO
Cancer; 1981 Mar; 47(6 Suppl):1614-9. PubMed ID: 6168355
[No Abstract] [Full Text] [Related]
[Next] [New Search]
